Improvement of non-steroidal anti-inflammatory drug-induced gastrointestinal symptoms during proton pump inhibitor treatment: are G-protein β3 subunit genotype, Helicobacter pylori status, and environmental factors response modifiers?

Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/5230

Full metadata record

DC Field	Value	Language
dc.contributor.author	Holtmann, Gerald	en
dc.contributor.author	van Rensburg, C	en
dc.contributor.author	Schwan, T	en
dc.contributor.author	Sander, P	en
dc.contributor.author	Siffert, W	en
dc.date.accessioned	2023-06-26T01:23:59Z	-
dc.date.available	2023-06-26T01:23:59Z	-
dc.date.issued	2011	-
dc.identifier.uri	https://dora.health.qld.gov.au/qldresearchjspui/handle/1/5230	-
dc.description.abstract	Non-steroidal anti-inflammatory drugs (NSAIDs) are associated with significant upper and lower gastrointestinal (GI) morbidity.	en
dc.language.iso	en	en
dc.relation.ispartof	Digestion	en
dc.title	Improvement of non-steroidal anti-inflammatory drug-induced gastrointestinal symptoms during proton pump inhibitor treatment: are G-protein β3 subunit genotype, Helicobacter pylori status, and environmental factors response modifiers?	en
dc.type	Article	en
dc.identifier.doi	10.1159/000331468	-
dc.identifier.pmid	22041889	-
dc.rights.holder	Holtmann, Gerald	en
item.grantfulltext	none	-
item.openairetype	Article	-
item.fulltext	No Fulltext	-
item.languageiso639-1	en	-
item.openairecristype	http://purl.org/coar/resource_type/c_18cf	-
item.cerifentitytype	Publications	-
Appears in Sites:	Gastroenterology and Hepatology, Princess Alexandra Hospital

98

checked on Apr 22, 2025

Check